/C O R R E C T I O N -- RyboDyn/

In the news release, RYBODYN AWARDED $1.3M DOW GRANT TO ADVANCE NOVEL ANTIBODY THERAPIES FOR LUNG CANCER, issued 09-Jul-2026 by RyboDyn over PR Newswire, we are advised by the company that changes have been made. The complete, corrected release follows, with additional details at the end:...